Latest filing published 03 Apr 2025 for SANOFI, €50k. Read the official filing
Not enough history yet: 0 closed purchases, at least 2 are needed.
John Sundy is a declared insider of Sanofi (board member), with filings sourced from AMF. Between 21 June 2024 and 2 April 2025, the trades on record add up to 3 filings.
The open-market record is one-sided, with 3 purchases worth €130k and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. So far in 2025, the count stands at 1 purchase and no sales.
The median purchase comes to €42k. The 3 purchases reviewed show no overlap with other insiders buying the same stock within a month.
The newest entry dates from 3 April 2025: an open-market purchase of €50k, in Sanofi. Between a trade and the moment it shows up on AMF, the median delay is 6 days. Under the Market Abuse Regulation, managers have three business days to notify their trades. Every figure here comes from the filings published by AMF and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations